Policy & Legislation
News on government policy and legislation impacting the life science and diagnostics markets.
Legislation is needed to improve pharmacogenetic and pharmacogenomic testing access and education, and to align reimbursement with guidelines, said experts at the Precision Med Tri-Con.
Illumina Cutting $100M in Fiscal 2025 Costs as Result of China Sequencer Import Ban
The company said it expects core adjusted EPS to be approximately $4.50 for the year, on the lower end of its previous guidance range.
Judge Issues Preliminary Injunction Blocking NIH Indirect Cost Cuts for Research Grants
Imminent risk to clinical trials and medical research "warranted the issuance of a nationwide temporary restraining order to maintain the status quo," the judge wrote.
Nobel Laureates Sign on to NYGC Petition to Reverse NIH Indirect Cost Cuts
More than 50 laureates signed the petition including well-known members of the genomics community such as Harold Varmus, Jennifer Doudna, Victor Ambros, Drew Weissman, and Carol Greider.
China Bans Import of Illumina Sequencers
The sanction was announced moments after the Trump administration's 20 percent tariffs on all Chinese exports to the US took effect on Tuesday.